SCHEMBL25601009

SCHEMBL25601009

O=c1[nH]c(=O)c2cc(Cl)c(Br)c(P)c2[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 1/20 0.38
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
CSNK2A1 P68400 1/20 0.38
TYMP P19971 5/20 0.33
DAO P14920 2/20 0.33
PNP P00491 1/20 0.33
GDA Q9Y2T3 1/20 0.32
KDM4E B2RXH2 4/20 0.32
CA12 O43570 1/20 0.32
PARP1 P09874 1/20 0.32
CA9 Q16790 1/20 0.32
ALDH1A1 P00352 3/20 0.31
GRIN2D O15399 3/20 0.31
GRIN3B O60391 3/20 0.31
GRIN1 Q05586 3/20 0.31
GRIN2A Q12879 3/20 0.31
GRIN2B Q13224 3/20 0.31
GRIN2C Q14957 3/20 0.31
GRIN3A Q8TCU5 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23540965 0.83 AR (0.41) IDH1CSNK2A2CSNK2BCSNK2A1TYMP
SCHEMBL29947950 0.83 AR (0.41) IDH1CSNK2A2CSNK2BCSNK2A1TYMP
SCHEMBL30168669 0.81 IDH1 (0.36) IDH1CSNK2A2CSNK2BCSNK2A1TYMP
SCHEMBL29388927 0.81 IDH1 (0.36) IDH1CSNK2A2CSNK2BCSNK2A1TYMP
SCHEMBL24791176 0.81 GRIN2D (0.38) IDH1CSNK2A2CSNK2BCSNK2A1TYMP
SCHEMBL23539934 0.81 IDH1 (0.36) IDH1CSNK2A2CSNK2BCSNK2A1TYMP
SCHEMBL16637455 0.81 IDH1 (0.36) IDH1CSNK2A2CSNK2BCSNK2A1TYMP
SCHEMBL7026627 0.75 IDH1 (0.35) IDH1CSNK2A2CSNK2BCSNK2A1TYMP
SCHEMBL7034331 0.74 GRIN2D (0.50) TYMPDAOGDAKDM4ECA12
SCHEMBL24790701 0.72 KDM4E (0.39) TYMPKDM4EALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023097195-A1 THERAPEUTIC INDAZOLE COMPOUNDS AND METHODS OF USE IN THE TREATMENT OF CANCER GENENTECH, INC. (US) 2023-06-01 WO disclosed